---
title: 'OvRSeq Analysis Report for 
TCGA-04-1331
'
output: pdf_document
date: "`r Sys.Date()`"
header-includes:
   - \usepackage{multicol}
   - \usepackage{graphicx}
---

## OvRSeq Analysis Results for Patient: TCGA-04-1331

The report starts with a Vulnerability Map highlighting HGSOC aspects, including BRCAness Status, Infiltration Status, and Tumor Molecular Subtypes, setting the stage for a personalized molecular analysis.

\begin{multicols}{2}

\includegraphics{./p1.jpeg}

\columnbreak

\textbf{Patient Values}

\begin{tabular}{cc}
\hline
Feature & Value \\
\hline
BRCAness Status & 1 (0.818) \\
Infiltration Status & Desert \\
Molecular Subtypes & PRO consensus \\
BRCAness immunotype & other \\
Vulnerability Score & 2.389 \\
Immuno Phenoscore & 1 \\
CYT to C1QA Ratio & 0.002 \\
Angiogenesis Score &  \\
\hline
\end{tabular}

\end{multicols}

\textbf{Molecular markers and TCGA-OV Reference Values}

This report section compares the patient's molecular markers with TCGA interquartile ranges (IQR). The table includes key markers like Immuno Phenoscore and CYT to C1QA ratio, crucial for personalized cancer profiling and treatment.

\begin{multicols}{2}

\includegraphics{./p2.jpeg}

\columnbreak

\begin{tabular}{lll}
\hline
Feature & Patient Value & TCGA IQR \\
\hline
CD274 & 1.21 & 1.325 (0.874-1.859) \\
GZMB & 2.149 & 2.548 (1.625-3.511) \\
PRF1 & 0.627 & 1.731 (1.152-2.505) \\
C1QA & 6.111 & 7.35 (6.411-8.18) \\
CD8A & 1.097 & 1.904 (1.168-2.648) \\
IDO1 & 4.113 & 4.161 (2.802-5.446) \\
FOXP3 & 1.748 & 1.938 (1.318-2.521) \\
TREM2 & 3.606 & 4.83 (3.761-5.638) \\
STAT1 & 7.266 & 7.015 (6.207-7.551) \\
HLA-DRA & 5.214 & 7.262 (6.298-8.001) \\
CXCL10 & 4.719 & 6.379 (5.032-7.539) \\
\hline
\end{tabular}

\end{multicols}

